150 related articles for article (PubMed ID: 16316831)
1. [Nasopharyngeal carcinoma in Tunisian children: retrospective epidemiological, clinical and biological study about 48 cases].
Jmal A; Boussen H; Ghanem A; Abaza H; Gara S; Douik H; Harzallah L; Benna F; Ladgham A; Guemira F
Bull Cancer; 2005 Nov; 92(11):977-81. PubMed ID: 16316831
[TBL] [Abstract][Full Text] [Related]
2. [Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
Frikha M; Toumi N; Ghorbel L; Ben Salah H; Khabir A; Karray H; Gargouri R; Boudawara T; Ghorbel A; Daoud J
Cancer Radiother; 2010 Jun; 14(3):169-75. PubMed ID: 20347607
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
Polychronopoulou S; Kostaridou S; Panagiotou JP; Stefanaki K; Papadakis V; Florentin L; Houlakis M; Christopoulos G; Haidas S
Pediatr Hematol Oncol; 2004; 21(5):393-402. PubMed ID: 15205082
[TBL] [Abstract][Full Text] [Related]
5. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma in Turkish children: review of 33 cases.
Berberoğlu S; Ilhan I; Cetindağ F; Sunter O
Pediatr Hematol Oncol; 2001; 18(5):309-15. PubMed ID: 11452402
[TBL] [Abstract][Full Text] [Related]
7. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of serum Cyfra 21-1 in nasopharyngeal carcinoma in Tunisia].
Jmal A; Boussen H; Abdennebi M; Gara S; Harzallah L; Gritli S; Ladgham A; Guemira F; Ghanem A
Bull Cancer; 2004 Apr; 91(4):369-72. PubMed ID: 15242321
[TBL] [Abstract][Full Text] [Related]
9. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of tumoral and lymph node response to neoadjuvant chemotherapy in undifferentiated nasopharyngeal carcinoma].
Frikha M; Bouaziz M; Daoud J; Ghorbel A; Elloumi M; Boudaya M; Jlidi R; Souissi T; Kechaou MS; Drira MM
Bull Cancer; 1997 Mar; 84(3):273-6. PubMed ID: 9207873
[TBL] [Abstract][Full Text] [Related]
11. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
[TBL] [Abstract][Full Text] [Related]
12. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
Farrell PJ
Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
[No Abstract] [Full Text] [Related]
13. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
Chen M; Lin S; Zheng W
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
[TBL] [Abstract][Full Text] [Related]
17. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis.
Lin YS; Lin LC; Lin SW
Laryngoscope; 2009 Jul; 119(7):1348-52. PubMed ID: 19402154
[TBL] [Abstract][Full Text] [Related]
18. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in metastatic nasopharyngeal carcinoma.
Khanfir A; Frikha M; Ghorbel A; Drira MM; Daoud J
Cancer Radiother; 2007 Dec; 11(8):461-4. PubMed ID: 17689126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]